Search Abstracts Program

Session 47   Poster Session DNA Vaccines 4:30-6:30 pm 4E-F

Click on the to view the poster for an abstract.

285-W.	Modification of HIV-1 nef and tat for DNA Vaccine Design D. Gurner*, Y. Huang, Z. Chen, Y. Song, W. Zhang, X. Zhao, and D. D. Ho Aaron Diamond AIDS Res. Ctr., Rockefeller Univ., New York, NY Add to Itinerary
286-W.	A Novel Topical DNA Vaccine (DermaVir) for the Induction of T-Cell Immunity J. Lisziewicz*1, J. Xu1, J. Trocio1, L. Whitman1, P. Markham2, S. Arya3, J-P. Behr4, and F. Lori1 1Res. Inst. for Genetic and Human Therapy (RIGHT), Washington, DC; 2Advanced BioSci. Labs. Inc., Rockville, MD; 3NCI, NIH, Bethesda, MD; and 4Faculte de Pharmacie, Illkirch, France Add to Itinerary
287-W.	Transmucosal Delivery of CpG ODN Applied to the Genital Mucosa Protects Mice against Intravaginal HSV-2 Infection D. Sajic*1, A. A. Ashkar1, A. J. Patrick1, M. J. McCluskie2, H. L. Davis2, K. L. Levine3, R. Holl3, and K. L. Rosenthal1 1McMaster Univ. Hlth. Sci. Ctr., Hamilton, ON, Canada; 2Coley Pharmaceutical Group, Ottawa, ON, Canada; and 3Atrix Labs., Fort Collins, CO Add to Itinerary
288-W.	Generating Novel HIV-1 Envelope Vaccine Candidates Using DNA Shuffling Technology L. Xu1, X. Du1, W. Zhang1, D. R. Burton2, P. W. H. I. Parren2, and R. G. Whalen*1 1Maxygen, Inc., Redwood City, CA and 2 Scripps Res. Inst., La Jolla, CA Add to Itinerary

---